These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29860313)

  • 1. Sigma 1 Receptor Antagonists Inhibit Manic-Like Behaviors in Two Congenital Strains of Mice.
    Sánchez-Blázquez P; Cortés-Montero E; Rodríguez-Muñoz M; Garzón J
    Int J Neuropsychopharmacol; 2018 Oct; 21(10):938-948. PubMed ID: 29860313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.
    Garzón-Niño J; Rodríguez-Muñoz M; Cortés-Montero E; Sánchez-Blázquez P
    Sci Rep; 2017 Feb; 7():43468. PubMed ID: 28240305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control.
    Rodríguez-Muñoz M; Sánchez-Blázquez P; Herrero-Labrador R; Martínez-Murillo R; Merlos M; Vela JM; Garzón J
    Antioxid Redox Signal; 2015 Apr; 22(10):799-818. PubMed ID: 25557043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands Exert Biased Activity to Regulate Sigma 1 Receptor Interactions With Cationic TRPA1, TRPV1, and TRPM8 Channels.
    Cortés-Montero E; Sánchez-Blázquez P; Onetti Y; Merlos M; Garzón J
    Front Pharmacol; 2019; 10():634. PubMed ID: 31249525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9.
    Sánchez-Blázquez P; Pozo-Rodrigálvarez A; Merlos M; Garzón J
    Mol Neurobiol; 2018 Jun; 55(6):4940-4951. PubMed ID: 28779350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders.
    Rodríguez-Muñoz M; Cortés-Montero E; Pozo-Rodrigálvarez A; Sánchez-Blázquez P; Garzón-Niño J
    Oncotarget; 2015 Nov; 6(34):35458-77. PubMed ID: 26461475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The σ1 Receptor and the HINT1 Protein Control α2δ1 Binding to Glutamate NMDA Receptors: Implications in Neuropathic Pain.
    Rodríguez-Muñoz M; Cortés-Montero E; Onetti Y; Sánchez-Blázquez P; Garzón-Niño J
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons.
    Hong J; Sha S; Zhou L; Wang C; Yin J; Chen L
    Cell Death Dis; 2015 Jul; 6(7):e1832. PubMed ID: 26203861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor.
    Rodríguez-Muñoz M; Onetti Y; Cortés-Montero E; Garzón J; Sánchez-Blázquez P
    Mol Brain; 2018 Sep; 11(1):51. PubMed ID: 30223868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Herrero-Labrador R; Burgueño J; Zamanillo D; Garzón J
    Int J Neuropsychopharmacol; 2014 Dec; 17(12):1943-55. PubMed ID: 24485144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats.
    Skuza G; Rogóz Z
    J Physiol Pharmacol; 2006 Jun; 57(2):217-29. PubMed ID: 16845227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma-1 receptor deficiency reduces GABAergic inhibition in the basolateral amygdala leading to LTD impairment and depressive-like behaviors.
    Zhang B; Wang L; Chen T; Hong J; Sha S; Wang J; Xiao H; Chen L
    Neuropharmacology; 2017 Apr; 116():387-398. PubMed ID: 28108357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Sigma-1 Receptor Alleviates Postpartum Estrogen Withdrawal-Induced "Depression" Through Restoring Hippocampal nNOS-NO-CREB Activities in Mice.
    Zhang S; Hong J; Zhang T; Wu J; Chen L
    Mol Neurobiol; 2017 May; 54(4):3017-3030. PubMed ID: 27032391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-related neurogenesis decrease in hippocampal dentate gyrus with depressive-like behaviors in sigma-1 receptor knockout mice.
    Sha S; Hong J; Qu WJ; Lu ZH; Li L; Yu WF; Chen L
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1275-86. PubMed ID: 25983018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by sigma-1 receptor agonists is synergic with donepezil, but not with memantine, in a mouse model of amyloid-induced memory impairments.
    Maurice T
    Behav Brain Res; 2016 Jan; 296():270-278. PubMed ID: 26386305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sigma-1 (σ₁) receptor deficiency reduces β-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B.
    Yin J; Sha S; Chen T; Wang C; Hong J; Jie P; Zhou R; Li L; Sokabe M; Chen L
    Neuropharmacology; 2015 Feb; 89():215-24. PubMed ID: 25286118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania.
    Abrial E; Bétourné A; Etiévant A; Lucas G; Scarna H; Lambás-Señas L; Haddjeri N
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25577667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of new sigma (σ) receptor ligands, PB190 and PB212, in the models predictive of antidepressant activity.
    Skuza G; Sadaj W; Kabziński M; Cassano G; Gasparre G; Abate C; Berardi F
    Pharmacol Rep; 2014 Apr; 66(2):320-4. PubMed ID: 24911087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma-1 receptor in brain ischemia/reperfusion: Possible role in the NR2A-induced pathway to regulate brain-derived neurotrophic factor.
    Xu Q; Ji XF; Chi TY; Liu P; Jin G; Chen L; Zou LB
    J Neurol Sci; 2017 May; 376():166-175. PubMed ID: 28431607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.